Delivery Order SPE2DB22D1106-SPE2DB23FETZ4
Award Date 8/3/23
Potential Completion Date 8/4/23
Potential Value $53K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $79,313 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to treat atopic dermatitis and asthma under a one-day period of performance at its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. This order was issued against an existing DLA pharmaceuticals contract vehicle to support the...
- The Defense Logistics Agency awarded a $13,938 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will deliver the medication to its place of performance in Conshohocken, Pennsylvania by August 11, 2023 to support DLA programs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, procuring critical pharmaceuticals and other medical...
- The Defense Logistics Agency awarded a $11,765.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The order is for 2ML pens of DUPIXENT, which is used to treat atopic dermatitis and asthma. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by August 31, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a $54,454.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order for DUPIXENT, which...
- The Defense Logistics Agency awarded a $16,364 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The DLA procures medical supplies and equipment for various DoD programs and stockpiles, so this order is likely supporting treatment for...
- The Defense Logistics Agency awarded a $33,482.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by September 6, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order...
- The Defense Logistics Agency awarded a $54,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will deliver the medication to its place of performance in Conshohocken, Pennsylvania by September 8, 2023 to support DLA programs. No subcontractors or set aside designations were identified. DLA manages the global supply chain for the Department of Defense, ensuring troops have the medical supplies and...
- The Defense Logistics Agency awarded a $43,857.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the product to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order for...
- The Defense Logistics Agency awarded a $17,338 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense, procuring all...
- The Defense Logistics Agency awarded a $118,039.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of DUPIXENT 300 MG/2 ML pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 2ML DUPIXENT pens to a facility in Conshohocken, Pennsylvania by September 18, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed by the DLA, the agency responsible for...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FETZ4Delivery Order
The Defense Logistics Agency awarded a $53,231 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to treat atopic dermatitis and asthma under a one-day period of performance at its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. This order is likely associated with DLA's medical supply vehicle to support the Department of Defense's treatment of conditions like atopic dermatitis and asthma among military personnel.
Generated 12/23/23, 10:52 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.2k | 8/3/23 |